Management of Vancomycin Trough Levels Exceeding 20 mg/L

Immediate Actions

When vancomycin trough levels exceed 20 mg/L, hold the next scheduled dose and recheck the trough level before administering subsequent doses to reduce the risk of nephrotoxicity 1
Measure a repeat trough level before administering the next dose to confirm the level has decreased to the target range (10-15 mg/L for most infections or 15-20 mg/L for severe infections) 1
Monitor serum creatinine closely for signs of nephrotoxicity, defined as multiple (at least 2-3 consecutive) increases in serum creatinine of 0.5 mg/dL or 150% increase from baseline 1

Once the trough level decreases to the target range, resume vancomycin at a reduced dose or with an extended dosing interval 1
For patients with normal renal function, consider reducing the dose by approximately 15-20% or extending the dosing interval 1
The target therapeutic range depends on the infection being treated: 10-15 μg/mL for less severe infections 2
The target therapeutic range for complicated infections such as bacteremia, endocarditis, osteomyelitis, meningitis, and hospital-acquired pneumonia is 15-20 μg/mL 1, 3

Sustained trough concentrations >20 μg/mL significantly increase the risk of nephrotoxicity 1

Continuing the same dosage despite elevated trough levels increases nephrotoxicity risk 1
Monitoring only peak levels provides limited clinical value 1
Discontinuing vancomycin therapy completely when still clinically indicated, rather than adjusting the dose, is not recommended 1
Failing to consider alternative therapies when vancomycin MIC is ≥2 mg/L, as target AUC/MIC ratios may not be achievable with conventional dosing 1

After dose adjustment, measure new trough levels before the fourth or fifth dose (in steady-state conditions) 3
Continue to monitor renal function throughout therapy 1